Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Asthma: full-pipeline trial registry
70 of 378 indexed Asthma trials are currently recruiting.
Corpus placement: #15 of 28,963 conditions by registered trial count.
378 US clinical trials · 70 currently recruiting · #15 of 28,963 conditions by registered trial count
Asthma: 378 US clinical trials tracked, 70 recruiting.
Asthma is the subject of 378 registered US clinical trials on ClinicalTrials.gov, 70 of them currently open to new participants. 89 are in Phase 3-4 (later-stage) and 108 in Phase 1-2 (earlier-stage). The most active sponsor is GlaxoSmithKline, running 24 of these trials.
Open enrollment snapshot
Asthma has 378 registered US clinical trials, 70 of them open to new participants right now, about 19% of the total.
- 70
- recruiting participants now
- 19%
- of trials open to enrollment
- 89
- in Phase 3-4 (later-stage)
- 24
- top sponsor: GlaxoSmithKline
Corpus placement: #15 of 28,963 conditions by registered trial count on ClinicalTrials.gov-derived indexes. Registry reference only, not medical advice.
Key findings
What ClinicalTrials.gov does not surface for Asthma on its own pages , computed from the registry mirror as of 2026-07-11. Each line carries its own denominator so it can be quoted as it stands.
-
Asthma is recruiting below its size-band peers.
70 of 378 indexed trials (18.5%) are open to enrollment, against a 37.2% average across 135 conditions with 100+ trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Asthma trials is spread across many organizations.
GlaxoSmithKline accounts for 24 of 378 trials (6.3%). 161 distinct sponsors appear on at least one study for this condition label.
-
Typical Asthma enrolment sits around 144 participants.
Median target enrolment is 144 among the 375 trials that report a genuine target (sentinel values excluded). 160 of those (42.7%) plan for fewer than 100 participants.
-
Asthma research is mostly interventional.
298 interventional and 80 observational studies make up this index (78.8% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
378 total, page 2 of 8
Supplementing L-citrulline to Overweight Late Asthma oNset Phenotypes
University of Colorado, Denver
NCT03885245
Viral Infection in Asthma (VIA) Study
University of Virginia
NCT04380038
Anti Inflammatory Lipid Mediators in Asthma Lipid Anti-Inflammtory Mediators in Asthma
University of Colorado, Denver
NCT03762395
NIOSH R21 WTC Asthma
Icahn School of Medicine at Mount Sinai
NCT07222501
Microglia Activation in Asthma
University of Wisconsin, Madison
NCT04307667
ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults
Enveda Therapeutics
NCT07301255
Obesity, Metabolic Dysregulation and the Airway Epithelium in Asthmatics
University of Colorado, Denver
NCT03215836
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Gelb, Arthur F., M.D.
NCT01225913
The Effects of Positive Airway Pressure on the Mucolytic Effects of NAC (TEAM)
University of California, San Francisco
NCT06152653
Measuring the Effect of Dupilumab Treatment on Mucociliary Clearance (MCC) in Subjects With Moderate to Severe Asthma
Sally E. Wenzel MD
NCT04743791
Automated Inhaler Monitoring for Asthma Medication Usage
Boston Children's Hospital
NCT06825871
SMART@Home Feasibility Trial
Children's Hospital Medical Center, Cincinnati
NCT06159127
Mechanistic Insights From Bronchoscopy Airway Samples
University of California, San Francisco
NCT06105710
Spirometric Response to Bronchial Thermoplasty in Patients With Severe Asthma
University of Oklahoma
NCT02241265
The Increase of Lung Capacity Using the Lung Master (Pulmonary Exerciser)
University of Nebraska
NCT06524856
Finding Correlations Between Asthma Exacerbation, Physiological Measurements and Environmental Factors
North Carolina State University
NCT04845932
AeviceMD for Pediatric Asthma Management
Irina Dralyuk
NCT06321471
Nutrition for Asthmatics
Pennington Biomedical Research Center
NCT06151405
A Study to Investigate How Budesonide and Formoterol Move Through the Body (Pharmacokinetics) When Delivered With Different Devices in Participants Aged 4 to Less Than 12 Years Old With Asthma
AstraZeneca
NCT07433569
CT-Based Changes in Bone and Marrow Among Patients on Oral Steroids
University of Iowa
NCT04518722
LungVITamin D and OmegA-3 Trial (lungVITAL)
Brigham and Women's Hospital
NCT01728571
Simultaneously Implementing Pathways for Improving Asthma, Pneumonia, and Bronchiolitis Care for Hospitalized Children
University of California, San Francisco
NCT05206695
Reduce IDentified UNcontrolled Asthma
Kaiser Permanente
NCT01449409
Combination Short-Acting BroNchodilator and Inhaled Corticosteroid Rescue Therapy on Health Outcomes in Routine Care
AstraZeneca
NCT06422689
Pragmatic Open - Label Randomized Clinical Trial of FF/UMEC/VI vs Non-ellipta Usual Care ICS-LABA for Adult Participants With Uncontrolled Asthma
GlaxoSmithKline
NCT06372496
Severe Asthma Research Program
Milton S. Hershey Medical Center
NCT01606826
Real World and Genomic Data Based Asthma Insight Through Network Analysis
Icahn School of Medicine at Mount Sinai
NCT06623435
A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR)
Vanderbilt University Medical Center
NCT03927820
Registry of Asthma Patients Initiating DUPIXENT®
Regeneron Pharmaceuticals
NCT04287621
A Study to Investigate the Effect on Lung Function of BDA Formulated With a Next Generation Propellant Compared With an Approved Asthma Treatment (BDA With HFA Propellant) in Participants With Asthma
AstraZeneca
NCT06502366
CAMP Air: Efficacy and Cost-effectiveness in Urban Adolescents
Columbia University
NCT05091034
Clinic Navigation and Home Visits to Improve Guideline-based Care and Outcomes in Low Income Minority Adults With Asthma
University of Pennsylvania
NCT04023422
REIMAGINE - Real World EvaluatIon of Mepolizumab in Severe Asthma achievinG on Treatment clinIcal remissioN, a prospEctive Study
GlaxoSmithKline
NCT06041386
Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study
Sanofi
NCT06033833
Addressing Quality of Life, Clinical Outcomes, and Mechanisms in Uncontrolled Asthma Following the DASH Dietary Pattern
University of Illinois at Chicago
NCT05251402
AIM2ACT: A Mobile Health Tool to Help Adolescents Self-Manage Asthma
University of Florida
NCT04448002
A Phase 2, Dose Ranging Study Assessing Rocatinlimab in Moderate-to-severe Asthma
Amgen
NCT06376045
A Dose Finding Study With an Anti-TSLP Antibody (GSK5784283) in Adults Aged 18 to 75 Years of Age With Uncontrolled Asthma
GlaxoSmithKline
NCT06748053
Transplacental Transmission of RSV (TTRSV)
Tulane University
NCT05443607
Airway Redox and Gender Determinants in Severe Asthma
The Cleveland Clinic
NCT01759186
Prevention of Asthma Exacerbations Using Dupilumab in Urban Children and Adolescents
National Institute of Allergy and Infectious Diseases (NIAID)
NCT05347771
Physical Activity Intervention for Black Women With Asthma
University of Chicago
NCT05726487
Preventing Asthma in High Risk Kids
Boston Children's Hospital
NCT02570984
AIRWEIGHS: Investigating Obesity as a Susceptibility Factor for Air Pollution in Childhood Asthma
Johns Hopkins University
NCT02763917
Upper Airway Microbial Development During the First Year of Life
Indiana University
NCT01978288
A Study to Investigate GB-0895 in Adults With Mild to Moderate Asthma or COPD
Generate Biomedicines
NCT07116889
Investigating Dupilumab's Effect in Asthma by Genotype
Boston Children's Hospital
NCT03694158
Vaginal Microbiome Exposure and Immune Responses in C-section Infants
National Institute of Allergy and Infectious Diseases (NIAID)
NCT03567707
Benralizumab Airway Remodeling Study in Severe Eosinophilic Asthmatics
AstraZeneca
NCT03953300
Symptom-driven ICS/LABA Therapy for Patients With Asthma Non-adherent to Daily Maintenance Inhalers
Washington University School of Medicine
NCT05111262
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 27 |
| Phase 2 | 81 |
| Phase 3 | 51 |
| Phase 4 | 38 |
Top Sponsors
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
What is open for Asthma right now
70 recruiting of 378 indexed (19% open).
Phase mix: 89 late (III/IV) vs 108 early (I/II) (balanced across stages).
Top sponsor: GlaxoSmithKline (24 trials), 9 others listed. 50 shown below, recruiting first. #15 of 28,963 conditions by registered trial count.
How open-enrollment share is computed
Open share is recruiting_count divided by trial_count for this condition label in the public registry export. Status can change between pulls; treat the figure as a snapshot of research attention, not treatment availability.
Frequently Asked Questions
How many clinical trials are there for Asthma?
PlainTrial tracks 378 US clinical trials for Asthma, of which 70 are currently recruiting participants. Data sourced from ClinicalTrials.gov.
How do I find a recruiting trial for Asthma?
Use the trial list above filtered by "Recruiting" status, or visit our trial finder at /recruiting to search by condition and state. Always discuss trial participation with your healthcare provider before enrolling.
Is this data current?
Data is sourced from ClinicalTrials.gov and reflects our most recent data pull. Trial status may have changed since then. Always verify current information at ClinicalTrials.gov before making decisions about participation.
Related
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from ClinicalTrials.gov (National Library of Medicine). Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2026 Trial counts and statuses sourced from ClinicalTrials.gov. Sponsor counts include both industry and federal/academic sponsors.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial for this condition, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.